CAS: 885220-61-1 - Verucerfont
Formula:C22H26N6O2
InChI:InChI=1S/C22H26N6O2/c1-7-18(22-24-15(5)27-30-22)25-19-11-13(3)23-21-20(14(4)26-28(19)21)17-9-8-16(29-6)10-12(17)2/h8-11,18,25H,7H2,1-6H3/t18-/m0/s1
InChI key:InChIKey=VKHVAUKFLBBZFJ-SFHVURJKSA-N
SMILES:N=1OC(=NC1C)C(NC2=CC(=NC3=C(C(=NN32)C)C=4C=CC(OC)=CC4C)C)CC
- Synonyms:
- Verucerfont
- Pyrazolo[1,5-a]pyrimidin-7-amine, 3-(4-methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]-
- NBI 77860
- 3-(4-Methoxy-2-methylphenyl)-2,5-dimethyl-N-[(1S)-1-(3-methyl-1,2,4-oxadiazol-5-yl)propyl]pyrazolo[1,5-a]pyrimidin-7-amine
- GSK 561679A
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Verucerfont REF: TM-T7361CAS: 885220-61-1 | 99.95% | 63.00 €~838.00 € | Tue 03 Dec 24 |
 | Verucerfont REF: 3D-KKB22061CAS: 885220-61-1 | Min. 95% | To inquire | Tue 07 Jan 25 |
Verucerfont
CAS:885220-61-1
Verucerfont (NBI77860) is an antagonist of corticotropin-releasing factor receptor 1 (CRF1) .
Formula:
C22H26N6O2
Purity:
99.95%
Color and Shape:
Solid
Molecular weight:
406.48
Ref: TM-T7361
| 1mg | 63.00 € | ||
| 2mg | 92.00 € | ||
| 5mg | 135.00 € | ||
| 10mg | 214.00 € | ||
| 25mg | 392.00 € | ||
| 50mg | 598.00 € | ||
| 100mg | 838.00 € | ||
| 200mg | 674.00 € | ||
| 1mL*10mM (DMSO) | 149.00 € |
Estimated delivery in United States, on Tuesday 3 Dec 2024
Verucerfont
CAS:885220-61-1
Verucerfont is a drug that binds to the glucocorticoid receptor and inhibits transcription. It has …
Formula:
C22H26N6O2
Purity:
Min. 95%
Molecular weight:
406.48 g/mol
Ref: 3D-KKB22061
| 10mg | To inquire | ||
| 25mg | To inquire | ||
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 7 Jan 2025
